Form 4: Nurix Therapeutics Executive Christine Ring Reports Stock Transactions
SEC Form 4
Christine Ring, Chief Legal Officer of Nurix Therapeutics, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.
Summary
- Christine Ring, the Chief Legal Officer of Nurix Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- The report includes the acquisition of common stock through the vesting of restricted stock units (RSUs).
- Ring also disposed of shares to cover tax withholding obligations related to the vesting of these RSUs.
- The transactions occurred on April 30, 2025.
- A total of 8,674 shares were acquired through RSU vesting.
- 2,894 shares were sold at a weighted average price of $11.5017 to cover tax obligations.
- Following these transactions, Ring beneficially owns 37,318 shares of common stock.
- Ring also holds derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates activity related to equity compensation and tax obligations, which is common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 04/30/2022 | First quarterly vesting increment for some RSUs. |
| 07/30/2023 | First quarterly vesting increment for some RSUs. |
| 07/30/2024 | First quarterly vesting increment for some RSUs. |
| 04/30/2025 | Date of the reported transactions (acquisition and disposal of shares). |
Keywords
Form 4, Nurix Therapeutics, NRIX, Christine Ring, Beneficial Ownership, Restricted Stock Units, Tax Withholding, Equity Incentive Plans, Sell to Cover
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.